Trillium Therapeutics Inc. (TSX: TR) (Formerly Stem Cell Therapeutics Corp.),
a Toronto-based biopharmaceutical development company, is Canada’s only public company
dedicated to advancing cancer stem cell discoveries into novel and innovative cancer
therapies. Building on over half a century of leading groundbreaking Canadian stem
cell research, we are supported by established links to multiple Toronto academic
institutes and oncology treatment centres that represent one of the world’s most
acclaimed cancer research hubs. A new Trillium Therapeutics website will be launched
in the near future.